Indian stocks: Visit www.stage2stocks.com →

Baird Medical Investment Holdings Ltd

Stage 4 · Declining · week 20

As of Oct 22, 2026, Baird Medical Investment Holdings is in Stage 4, the downtrend phase, now in week 20 (since Jun 8, 2026). It closed at $0.45, 86.8% below its 52-week high and below its 200-day average, which is falling.

Baird Medical Investment Holdings Limited, together with its subsidiaries, engages in research, development, manufacturing, and sales of microwave ablation and other medical devices in the People's Republic of China. More about the company

$0.45
-4.83% today
$14.5M · Micro cap
Market Neutral — Building

Pro read

Pro

Our read

Declining, below its long-term trend

Setup score

—

Momentum

Steady

Edge

—

Is BDMD early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…
Stage Cycle Timeline2023-08-16 → 2026-10-22
S2 59w
S4 14w
S4 33w
S4 20w
2023-08-162026-10-22
S1S2S3S4Setup score (0–10, dashed line at 5)
S2 59w → S3 1w → S4 14w → S1 11w → S4 6w → S1 3w → S4 3w → S3 3w → S4 33w → S1 6w → S2 4w → S3 3w → S4 20w current
Total tracked: 165 weeks across 13 stage runs.

BDMD among Medical Devices101st of 141 by relative strength

All 141 →
Stocks in Medical Devices ranked by relative strength, with stage and one-month change
#StockStageRS1M
1TXGStage 2 · wk 4899−7.8%
2RCELStage 2 · wk 1398+40.8%
3BFLYStage 2 · wk 2698−26.0%
4HAEStage 2 · wk 1796+8.7%
5GKOSStage 2 · wk 2596+15.1%
6AXGNStage 3 · wk 295−15.3%
7NEOGStage 2 · wk 1495−11.7%
8BVSStage 2 · wk 1595+10.5%
…101BDMDStage 4 · wk 2015−42.7%
vs 52W High
-86.8%
$0.44 lo$3.44 hi
86.8% below 52W high, deep Stage 4 damage
In Stage 4, distance from the 52-week high reflects an ongoing decline, not a discount.
Stage Maturity
Week 20
1w13w26w
Week 20, established downtrend
How long this stock has been in Stage 4 decline. The longer the downtrend, the more entrenched the selling pressure. No length of decline marks a bottom on its own.
vs 200 DMA
-66.9%
200 DMA: $1.37 · sloping down
In Stage 4, the stock is below its 200-day average, the hallmark of a downtrend. Stage analysis waits for that to reverse before buying.
Rel Volume
0.61x
vs 50-day avg
High volume on down days in Stage 4 confirms institutional selling. Low-volume bounces are typical. They lack real buyers and are easy to mistake for reversals.
Trend Health
↓
Short-term trend rolling over
Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.
1M
-42.7%
3M
-55.6%
6M
-73.4%
YTD
-66.2%
1Y
-71.5%
Scan Membership
Breakout Watch
Latest: 2022-10-03
A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.
Recent Stage Timeline
2026-10-22S4
Wk 20 · Vol 0.61x
2026-10-21S4
Wk 19 · Vol 0.53x
2026-10-20S4
Wk 19 · Vol 0.98x
2026-10-19S4
Wk 19 · Vol 3.24x
2026-10-16S4
Wk 19 · Vol 0.92x
2026-10-15S4
Wk 19 · Vol 1.40x
2026-10-14S4
Wk 18 · Vol 2.28x
2026-10-13S4
Wk 18 · Vol 0.78x
2026-10-12S4
Wk 18 · Vol 1.21x
2026-10-09S4
Wk 18 · Vol 0.90x
2026-10-08S4
Wk 18 · Vol 1.22x
2026-10-07S4
Wk 17 · Vol 1.18x
Moving averages & range
50 DMA
$0.92
200 DMA
$1.37
52W High
$3.44
52W Low
$0.44
5D Low
$0.44
Resistance levels (recent highs)
20d High
$0.80
60d High
$1.22
120d High
$1.86
250d High
$3.44
Next resistance
+76.2%
to 20d High
ROE
-46.0%
Profit margin -65.1%
Dividend Yield
0.00%
P/B 0.4

Baird Medical Investment Holdings: quick answers

What stage is Baird Medical Investment Holdings in?

As of Oct 22, 2026, Baird Medical Investment Holdings (BDMD) is in Stage 4, the downtrend phase. It entered Stage 4 on Jun 8, 2026 and is in week 20. What the four stages mean

Is Baird Medical Investment Holdings in an uptrend?

No. Baird Medical Investment Holdings is in a Stage 4 downtrend. It trades 66.9% below its 200-day average, which is falling.

How far is Baird Medical Investment Holdings from its 52-week high?

Baird Medical Investment Holdings closed at $0.45 on Oct 22, 2026, 86.8% below its 52-week high of $3.44. Its 52-week low is $0.44.

How has Baird Medical Investment Holdings performed over the past year?

As of Oct 22, 2026, Baird Medical Investment Holdings is down 71.5% over the past year and down 66.2% so far in 2026.

Which sector and industry is Baird Medical Investment Holdings in?

Baird Medical Investment Holdings is in the Medical Devices industry, part of the Health Care sector.

About this companyHealth Care· Medical Devices

Baird Medical Investment Holdings Limited, together with its subsidiaries, engages in research, development, manufacturing, and sales of microwave ablation and other medical devices in the People's Republic of China. The company offers microwave ablation apparatus and needles; and long and fine microwave ablation needles for the treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer, and breast lumps, and uterine fibroids, as well as soft tissue ablation. It sells its products through third-party distributors. It has a strategic cooperation agreement with Tianjin Yuanshan Medical Technology Co., Ltd. to focus on global development and commercialization of next-generation IRE technologies. Baird Medical Investment Holdings Limited was founded in 2012 and is based in Guangzhou, China.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.